rs17618172
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_014421.3(DKK2):c.223-53909T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 152,254 control chromosomes in the GnomAD database, including 3,359 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.20 ( 3359 hom., cov: 32)
Consequence
DKK2
NM_014421.3 intron
NM_014421.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.114
Publications
5 publications found
Genes affected
DKK2 (HGNC:2892): (dickkopf WNT signaling pathway inhibitor 2) This gene encodes a protein that is a member of the dickkopf family. The secreted protein contains two cysteine rich regions and is involved in embryonic development through its interactions with the Wnt signaling pathway. It can act as either an agonist or antagonist of Wnt/beta-catenin signaling, depending on the cellular context and the presence of the co-factor kremen 2. Activity of this protein is also modulated by binding to the Wnt co-receptor LDL-receptor related protein 6 (LRP6). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.409 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DKK2 | ENST00000285311.8 | c.223-53909T>C | intron_variant | Intron 1 of 3 | 1 | NM_014421.3 | ENSP00000285311.3 | |||
DKK2 | ENST00000513208.5 | c.-78-53909T>C | intron_variant | Intron 2 of 4 | 1 | ENSP00000421255.1 | ||||
DKK2 | ENST00000510534.1 | n.444-53909T>C | intron_variant | Intron 1 of 2 | 1 | |||||
DKK2 | ENST00000510463.1 | c.85-53909T>C | intron_variant | Intron 3 of 5 | 3 | ENSP00000423797.1 |
Frequencies
GnomAD3 genomes AF: 0.200 AC: 30465AN: 152136Hom.: 3355 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
30465
AN:
152136
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.200 AC: 30499AN: 152254Hom.: 3359 Cov.: 32 AF XY: 0.205 AC XY: 15230AN XY: 74444 show subpopulations
GnomAD4 genome
AF:
AC:
30499
AN:
152254
Hom.:
Cov.:
32
AF XY:
AC XY:
15230
AN XY:
74444
show subpopulations
African (AFR)
AF:
AC:
5801
AN:
41554
American (AMR)
AF:
AC:
4642
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
709
AN:
3470
East Asian (EAS)
AF:
AC:
2189
AN:
5168
South Asian (SAS)
AF:
AC:
1283
AN:
4828
European-Finnish (FIN)
AF:
AC:
2217
AN:
10608
Middle Eastern (MID)
AF:
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
AC:
13023
AN:
68018
Other (OTH)
AF:
AC:
421
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1232
2464
3695
4927
6159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1084
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.